维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="LACY MK"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Moxifloxacin:clinical efficacy and safety显示文摘	Culley CM Lacy MK Klutman N	2001	Am JHcalth Syst Pharm2001，58，5：	1
2	Moxi-floxacin: clinical efficacy and safety显示文摘	Culley CM Lacy MK Klutman N	2001	Am J Health Syst Pham2001，58，5：	1
3	Moxifloxacin:clinical efficacy and safety显示文摘	Culley CM Lacy MK Klutman N	2001	Am J Health Syst Pharm2001，58，5：	1
4	Moxifloxacin:clinical efficacy and safety显示文摘	Culley CM Lacy MK Klutman N et a1	2001	Am J Health Syst Pharm2001，58，5：	1
5	Moxifloxacin:Clinincal efficacy and Safety显示文摘	CUlley CM Lacy MK Klutman N	2001	Am J Health SySt Pharm2001，58，5：	1
6	Pharmacodynamic comparaisons of levofloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in a vitro model of infection 显示文摘	Lacy MK Lu M Xu X	1999	Antimicrob Agents Chemother1999，43，3：	1
7	Moxifloxacin:clinical efficacy and safety显示文摘	Cully CM Lacy MK Klutmen N	2001	Am J Health Syst Pharm2001，58，5：	1
8	Moxifloxaein:clinieal efficacy and safety显示文摘	Culley CM Lacy MK Klutman N		0，，05：	1
9	Moxifloxacin:clinical efficacy and safety显示文摘	Culley CM Lacy MK Klutman N	2001	Am J Health Syst Pharm2001，58，5：	1
10	Moxifloxacin: clinical efficacy and safety显示文摘	Cully CM Lacy MK Klutmen N	2001	Am J Health Syst Pharm2001，58，5：	1
11	Pharmacodynamic comparisons of levofloxacin,ciprofloxacin,and ampicillin against Streptococcus pneumoniae in an in vitro model of infection显示文摘	Lacy MK Lu W Xu X	1999	Antimicrob Agents Chemother1999，43，3：	1
12	Moxifloxacin: clinical efficacy and safety显示文摘	Cully CM Lacy MK Klutmen N	2001	Am J Health Syst Pharm2001，58，5：	1
13	Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia显示文摘	McNabb J Lacy MK	2001	Int J Antimicrob Agents2001，17，：	1
14	Moxifloxacin:clinical efficacy and safety显示文摘	Culley CM Lacy MK Klutman N	2001	Am J Health Syst Pharm2001，58，5：	1
15	Moxifloxacin: clinical efficacy and safety显示文摘	Culley CM Lacy MK Klutman N	2001	Am J Health Syst Pharm2001，58，5：	1
16	The pharmacodynamics of aminoglycosides显示文摘	Nicolau DP Nightingale Cl H	1998	Clin Infect Dis1998，27，：	1
17	Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin-resistant staphylococci显示文摘	Lacy MK Tessier PR Nicolau DP	2000	Int J A ntimicrob Agents2000，15，1：	1
18	Moxifloxacin;Clinical efficacy and safety显示文摘	Culley CM Lacy MK Klutman N	2001	Am J Health Syst Pharm2001，58，5：	1
19	Moxifloxacin: clinical efficacy and safety显示文摘	CULLEY CM LACY MK KLUTMAN N	2001	Am J Health Syst Pharm2001，58，5：	1
20	Nationwide antibiogram analysis using NCCLS M39-A guidelines 显示文摘	Zapantis A Lacy MK Horvat RT	2005	J Clin Mirobiol2005，43，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示